Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors), Epigenetic drug |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Preclinical | United States | 08 Oct 2025 | |
| Amyotrophic Lateral Sclerosis | Preclinical | United States | 08 Oct 2025 | |
| Amyotrophic Lateral Sclerosis | Preclinical | United Kingdom | 08 Oct 2025 | |
| Frontotemporal Dementia | Preclinical | United States | 08 Oct 2025 | |
| Frontotemporal Dementia | Preclinical | United States | 08 Oct 2025 | |
| Frontotemporal Dementia | Preclinical | United Kingdom | 08 Oct 2025 |





